September 1st, 2020 (Lure, France) – Vetoquinol confirms the completion of the acquisition of Profender® and Drontal® product families for the European Economic Area and the UK. This acquisition is effective from August 1st, 2020.
Vetoquinol has acquired the Profender® and Drontal® product families, the intellectual property, registrations and other rights previously owned by Bayer AG’s animal health business. The Profender® and Drontal® families of products are spot-on and tablet de-wormer products for cats and dogs.
Vetoquinol’s acquisition of Profender® and Drontal® is related to Elanco’s acquisition of Bayer AG’s animal health business, which was finalized on August 1st 2020.
Matthieu Frechin, CEO of Vetoquinol, said "We are extremely pleased to share the completion of the acquisition of the Profender® and Drontal® product lines. These two strong brands fit perfectly at the core of Vetoquinol strategy. From now on, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. Also, effective immediately, these products and brands strengthen our portfolio of Essentials, the engine of our growth. I am proud of the Vetoquinol teams who made this deal happen despite the challenging circumstances brought by the global COVID outbreak.”
Latest news of vetoquinol
17 Nov 2020The 2021 ranking of companies with the best CSR Reputation in France was published on Thursday 12th November by the French magazine "Le Point"....
15 Oct 2020Vetoquinol posted sales of €114.5 million for the third quarter of 2020, up 14.3% as reported compared to the same period last year. All...